Shares of AmerisourceBergen Corp. (NYSE:ABC) have received an average rating of “Hold” from the twelve research firms that are covering the stock, MarketBeat Ratings reports. Three research analysts have rated the stock with a sell recommendation, six have issued a hold recommendation and two have assigned a buy recommendation to the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $86.00.
ABC has been the subject of a number of recent analyst reports. TheStreet downgraded AmerisourceBergen from a “b” rating to a “c+” rating in a research note on Tuesday, March 19th. ValuEngine upgraded AmerisourceBergen from a “sell” rating to a “hold” rating in a report on Thursday, January 31st. UBS Group started coverage on AmerisourceBergen in a report on Thursday, January 17th. They set a “buy” rating and a $89.00 price objective for the company. Zacks Investment Research lowered AmerisourceBergen from a “hold” rating to a “sell” rating in a report on Thursday, March 14th. Finally, Guggenheim started coverage on AmerisourceBergen in a research note on Thursday, April 11th. They issued a “buy” rating for the company.
NYSE:ABC traded down $1.71 during trading on Friday, reaching $77.47. The company’s stock had a trading volume of 1,336,129 shares, compared to its average volume of 1,434,701. The company has a market capitalization of $16.28 billion, a PE ratio of 11.94, a price-to-earnings-growth ratio of 1.54 and a beta of 1.07. The company has a debt-to-equity ratio of 1.43, a current ratio of 0.95 and a quick ratio of 0.56. AmerisourceBergen has a 12 month low of $69.36 and a 12 month high of $94.88.
AmerisourceBergen (NYSE:ABC) last announced its quarterly earnings data on Thursday, May 2nd. The company reported $2.11 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.96 by $0.15. The firm had revenue of $43.32 billion during the quarter, compared to the consensus estimate of $43.44 billion. AmerisourceBergen had a return on equity of 46.24% and a net margin of 0.53%. The business’s revenue for the quarter was up 5.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.94 EPS. Sell-side analysts anticipate that AmerisourceBergen will post 6.81 earnings per share for the current year.
The company also recently announced a quarterly dividend, which will be paid on Monday, June 3rd. Investors of record on Monday, May 20th will be paid a $0.40 dividend. The ex-dividend date is Friday, May 17th. This represents a $1.60 dividend on an annualized basis and a yield of 2.07%. AmerisourceBergen’s dividend payout ratio (DPR) is 24.65%.
In other AmerisourceBergen news, EVP Dale Danilewitz sold 543 shares of the firm’s stock in a transaction that occurred on Tuesday, April 23rd. The shares were sold at an average price of $71.20, for a total value of $38,661.60. Following the transaction, the executive vice president now directly owns 1,628 shares of the company’s stock, valued at approximately $115,913.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO James F. Cleary, Jr. bought 2,000 shares of the firm’s stock in a transaction on Wednesday, March 6th. The stock was acquired at an average cost of $77.52 per share, for a total transaction of $155,040.00. Following the completion of the purchase, the chief financial officer now directly owns 7,306 shares in the company, valued at $566,361.12. The disclosure for this purchase can be found here. In the last 90 days, insiders purchased 2,018 shares of company stock valued at $156,471 and sold 66,982 shares valued at $5,565,339. Company insiders own 27.80% of the company’s stock.
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Clarus Wealth Advisors raised its position in shares of AmerisourceBergen by 12.2% during the 4th quarter. Clarus Wealth Advisors now owns 1,308 shares of the company’s stock valued at $97,000 after buying an additional 142 shares during the period. Iowa State Bank raised its position in shares of AmerisourceBergen by 1.3% during the 1st quarter. Iowa State Bank now owns 10,963 shares of the company’s stock valued at $872,000 after buying an additional 144 shares during the period. Lenox Wealth Management Inc. raised its position in shares of AmerisourceBergen by 2.0% during the 4th quarter. Lenox Wealth Management Inc. now owns 8,379 shares of the company’s stock valued at $623,000 after buying an additional 163 shares during the period. Edmp Inc. raised its position in shares of AmerisourceBergen by 1.3% during the 1st quarter. Edmp Inc. now owns 12,857 shares of the company’s stock valued at $1,022,000 after buying an additional 165 shares during the period. Finally, Mason Street Advisors LLC raised its position in shares of AmerisourceBergen by 0.8% during the 1st quarter. Mason Street Advisors LLC now owns 22,285 shares of the company’s stock valued at $1,772,000 after buying an additional 174 shares during the period. 66.61% of the stock is currently owned by institutional investors and hedge funds.
AmerisourceBergen Company Profile
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers.
Featured Article: Overbought
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.